Unconfigured Ad
Collapse
X
-
-
The authors who publish an aligner are often required to compare and contrast with existing tools. So you can reads the papers associated with aligners of interest and see if the authors convince you to use their aligner. Of course, the authors have an unavoidable bias towards their own aligner in this scenario.
A number of bloggers have discussed the question informally online. For example:
This month I’ve come across some interesting statistics on the performance of Maq, Eland, and other short-read alignment tools as applied to Illumina/Solexa data. I took note because these pr…
Ideally, there would be a paper(s) written by a group that did not have their own aligner that did an objective comparison of many aligners. To be most useful, the comparison would be done with different applications in mind. These applications might have different aligner requirements (e.g. mutation discovery, expression profiling, miRNAs, ChIP-Seq, etc.).
I'm not aware of such a publication right now. Maybe someone else is and will post it. Unfortunately, journal editors (and reviewers) seem notoriously merciless towards such manuscripts ... Anything that fits into a 'platform comparison' category is automatically deemed to be less scientifically valuable, not novel, etc. Indeed some journals explicitly ban submission of this type of work.
-
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 11:13 AM
|
0 responses
16 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 11:13 AM
|
||
|
Started by SEQadmin2, Yesterday, 10:48 AM
|
0 responses
17 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
35 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
42 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Comment